Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: A pilot study

Vito Lorusso, Annamaria Catino, Francesco Schittulli, Salvatore Longo, Angela Racanelli, Artur Timurian, Franco Marzullo, Giovanni Simone, Mario Brandi, Mario De Lena

Research output: Contribution to journalArticlepeer-review

Abstract

From February 1992 to November 1993, forty patients with operable breast cancer tumors larger than three centimeters were enrolled in this study of accelerated neoadjuvant chemotherapy. Thirty-seven patients are evaluable: one patient was excluded from the protocol and two refused to continue treatment after the first cycle. Chemotherapy consisted of three presurgical cycles of CNF [cyclophosphamide at 600 mg/m2, mitoxantrone (Novantrone) at 10 mg/m2 and 5-fluorouracil at 600 mg/m2] administered every 2 weeks, plus G-CSF (5 μg/kg s.c./day on days 7-12). Twenty-six of 37 patients (70%) achieved objective tumor response and were submitted to quadrantectomy. Toxicity was easily manageable. After a median 55-month follow-up (range 48- 70), no locoregional recurrences were observed. Distant metastases occurred in 12/37 (32%) patients. The five-year disease-free (DFS) and overall (OS) survival were 58% and 80%, respectively. Accelerated CNF plus G-CSF proved to be a safe and tolerable regimen yielding a good clinical response thereby increasing the possibility of breast conservation surgery for patients otherwise candidates for mastectomy.

Original languageEnglish
Pages (from-to)1177-1181
Number of pages5
JournalInternational Journal of Oncology
Volume12
Issue number5
Publication statusPublished - May 1998

Keywords

  • Accelerated chemotherapy
  • Breast cancer
  • Granulocyte- colony stimulating factor
  • Primary chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint

Dive into the research topics of 'Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: A pilot study'. Together they form a unique fingerprint.

Cite this